|
1
|
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.
|
Health Qual Life Outcomes
|
2013
|
1.26
|
|
2
|
Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections.
|
Sex Transm Dis
|
2006
|
1.05
|
|
3
|
The effect of health, socio-economic position, and mode of data collection on non-response in health interview surveys.
|
Scand J Public Health
|
2010
|
1.02
|
|
4
|
Decomposition of health inequality by determinants and dimensions.
|
Health Econ
|
2007
|
1.02
|
|
5
|
International vision requirements for driver licensing and disability pensions: using a milestone approach in characterization of progressive eye disease.
|
Clin Ophthalmol
|
2010
|
1.01
|
|
6
|
[The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark].
|
Ugeskr Laeger
|
2005
|
0.96
|
|
7
|
Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey.
|
J Med Econ
|
2013
|
0.91
|
|
8
|
Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease.
|
Int J Technol Assess Health Care
|
2005
|
0.88
|
|
9
|
Benchmarks for interpretation of score differences on the SF-36 health survey for patients with diabetes.
|
Value Health
|
2013
|
0.88
|
|
10
|
Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective.
|
Patient Prefer Adherence
|
2013
|
0.85
|
|
11
|
Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries.
|
Qual Life Res
|
2014
|
0.76
|
|
12
|
Costs of informal care for people suffering from dementia: evidence from a danish survey.
|
Dement Geriatr Cogn Dis Extra
|
2011
|
0.75
|
|
13
|
[Can Danish health care registries provide data for specific drug-related hospital admissions in type 2 diabetes?].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
14
|
Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal-bolus regimen.
|
J Med Econ
|
2011
|
0.75
|